1-13 of 13
Robert L. Camp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1753: High expression of the microtubule destabilizing protein stathmin is prognostic for worse outcome in breast cancer

Maria Baquero, Jason Hanna, Seema Agarwal, Elizabeth Killiam, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1753.
https://doi.org/10.1158/1538-7445.AM10-1753
Published: 15 April 2010
View article titled, Abstract 1753: High expression of the microtubule destabilizing protein stathmin is prognostic for worse outcome in breast cancer
Journal Articles

High HSP90 Expression Is Associated with Decreased Survival in Breast Cancer

Elah Pick, Yuval Kluger, Jennifer M. Giltnane, Christopher Moeder, Robert L. Camp, David L. Rimm, Harriet M. Kluger
Journal: Cancer Research
Cancer Res (2007) 67 (7): 2932–2937.
https://doi.org/10.1158/0008-5472.CAN-06-4511
Published: 04 April 2007
View article titled, High HSP90 Expression Is Associated with Decreased Survival in Breast Cancer
Open the PDF for High HSP90 Expression Is Associated with Decreased Survival in Breast Cancer in another window
Journal Articles

Quantitative In situ Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome

Marisa Dolled-Filhart, Anthony McCabe, Jennifer Giltnane, Melissa Cregger, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2006) 66 (10): 5487–5494.
https://doi.org/10.1158/0008-5472.CAN-06-0100
Published: 16 May 2006
View article titled, Quantitative <em>In situ</em> Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome
Open the PDF for Quantitative <em>In situ</em> Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome in another window
Journal Articles

Quantitative multiplexed analysis of primary malignant melanoma defines a set of protein biomarkers that stratify patients by outcome within Breslow groups

Aaron J. Berger, Melissa Cregger, Michael Krauthammer, Kyle Divito, Gretchen Graff, Stephen Ariyan, Harriet Kluger, Ruth Halaban, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 273.
Published: 15 April 2006
View article titled, Quantitative multiplexed analysis of primary malignant melanoma defines a set of protein biomarkers that stratify patients by outcome within Breslow groups
Journal Articles

Prognostic analysis of HER pathway expression by objective quantitative analysis (AQUA) in a cohort of over 200 non-small cell lung cancers

Mark D. Gustavson, Jena Giltnane, Robert L. Camp, John Murren, David L. Rimm
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1064.
Published: 15 April 2006
View article titled, Prognostic analysis of HER pathway expression by objective quantitative analysis (AQUA) in a cohort of over 200 non-small cell lung cancers
Journal Articles

Using a Xenograft Model of Human Breast Cancer Metastasis to Find Genes Associated with Clinically Aggressive Disease

Harriet M. Kluger, Dina Chelouche Lev, Yuval Kluger, Mary M. McCarthy, Galina Kiriakova, Robert L. Camp, David L. Rimm, Janet E. Price
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5578–5587.
https://doi.org/10.1158/0008-5472.CAN-05-0108
Published: 01 July 2005
View article titled, Using a Xenograft Model of Human Breast Cancer Metastasis to Find Genes Associated with Clinically Aggressive Disease
Open the PDF for Using a Xenograft Model of Human Breast Cancer Metastasis to Find Genes Associated with Clinically Aggressive Disease in another window
Journal Articles

Quantitative analysis of AP-2 transcription factor in malignant melanoma provides molecular model for outcome prediction

Aaron J. Berger, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1155.
Published: 01 May 2005
View article titled, Quantitative analysis of AP-2 transcription factor in malignant melanoma provides molecular model for outcome prediction
Journal Articles

Protein expression profiling of the HER receptor family using automated quantitative analysis (AQUA) of breast cancer tissue microarrays

Jena M. Giltnane, Marisa Dolled-Filhart, David A. Eberhard, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 739.
Published: 01 May 2005
View article titled, Protein expression profiling of the HER receptor family using automated quantitative analysis (AQUA) of breast cancer tissue microarrays
Journal Articles

Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma

Kyle A. DiVito, Aaron J. Berger, Robert L. Camp, Marisa Dolled-Filhart, David L. Rimm, Harriet M. Kluger
Journal: Cancer Research
Cancer Res (2004) 64 (23): 8773–8777.
https://doi.org/10.1158/0008-5472.CAN-04-1387
Published: 01 December 2004
View article titled, Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma
Open the PDF for Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma in another window
Journal Articles

Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome

Aaron J. Berger, Robert L. Camp, Kyle A. DiVito, Harriet M. Kluger, Ruth Halaban, David L. Rimm
Journal: Cancer Research
Cancer Res (2004) 64 (23): 8767–8772.
https://doi.org/10.1158/0008-5472.CAN-04-1384
Published: 01 December 2004
View article titled, Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome
Open the PDF for Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome in another window
Journal Articles

Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome

Robert L. Camp, Marisa Dolled-Filhart, Bonnie L. King, David L. Rimm
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1445–1448.
Published: 01 April 2003
View article titled, Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome
Open the PDF for Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome in another window
Journal Articles

Tissue Microarray Analysis of Hepatocyte Growth Factor/Met Pathway Components Reveals a Role for Met, Matriptase, and Hepatocyte Growth Factor Activator Inhibitor 1 in the Progression of Node-negative Breast Cancer

Jung Y. Kang, Marisa Dolled-Filhart, Idris Tolgay Ocal, Baljit Singh, Chen-Yong Lin, Robert B. Dickson, David L. Rimm, Robert L. Camp
Journal: Cancer Research
Cancer Res (2003) 63 (5): 1101–1105.
Published: 01 March 2003
View article titled, Tissue Microarray Analysis of Hepatocyte Growth Factor/Met Pathway Components Reveals a Role for Met, Matriptase, and Hepatocyte Growth Factor Activator Inhibitor 1 in the Progression of Node-negative Breast Cancer
Open the PDF for Tissue Microarray Analysis of Hepatocyte Growth Factor/Met Pathway Components Reveals a Role for Met, Matriptase, and Hepatocyte Growth Factor Activator Inhibitor 1 in the Progression of Node-negative Breast Cancer in another window
Journal Articles

Alterations of Smad Signaling in Human Breast Carcinoma Are Associated with Poor Outcome: A Tissue Microarray Study

Wen Xie, Joachim C. Mertens, Daniel J. Reiss, David L. Rimm, Robert L. Camp, Bruce G. Haffty, Michael Reiss
Journal: Cancer Research
Cancer Res (2002) 62 (2): 497–505.
Published: 01 January 2002
View article titled, Alterations of Smad Signaling in Human Breast Carcinoma Are Associated with Poor Outcome: <subtitle>A Tissue Microarray Study</subtitle>
Open the PDF for Alterations of Smad Signaling in Human Breast Carcinoma Are Associated with Poor Outcome: <subtitle>A Tissue Microarray Study</subtitle> in another window